ChemicalBook > CAS DataBase List > CERIVASTATIN SODIUM

CERIVASTATIN SODIUM

Product Name
CERIVASTATIN SODIUM
CAS No.
145599-86-6
Chemical Name
CERIVASTATIN SODIUM
Synonyms
BAYCOL;LIPOBAY;RIVASTATIN;Cerivastatin;CERIVASTATIN NA;CERIVASTATIN, SODIUM SALT;Cerivastatin See C277000;CERIVASTATIN SODIUM USP/EP/BP;7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate;6-[2-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]ethenyl]-4-hydroxy-2-oxanone
CBNumber
CB2115263
Molecular Formula
C26H34FNO5
Formula Weight
459.55
MOL File
145599-86-6.mol
More
Less

CERIVASTATIN SODIUM Property

Melting point:
>176oC (dec.)
Boiling point:
646.3±55.0 °C(Predicted)
Density 
1.181±0.06 g/cm3(Predicted)
storage temp. 
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
solubility 
Ethanol (Slightly), Methanol (Slightly), Water (Slightly)
form 
Solid
pka
pKa 4.38 (H2O t=25 I=0.025) (Uncertain);5.29(H2O t=25 I=0.025) (Uncertain)
color 
White to Off-White
Stability:
Hygroscopic
CAS DataBase Reference
145599-86-6(CAS DataBase Reference)
EPA Substance Registry System
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1- methylethyl)-3-pyridinyl]-3,5-dihydroxy-, (3R,5S,6E)- (145599-86-6)
More
Less

Safety

Hazardous Substances Data
145599-86-6(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Usbiological
Product number
C2830
Product name
Cerivastatin, Sodium Salt
Packaging
5mg
Price
$396
Updated
2021/12/16
AHH
Product number
MT-49111
Product name
Cerivastatin
Purity
98%
Packaging
0.1g
Price
$410
Updated
2021/12/16
More
Less

CERIVASTATIN SODIUM Chemical Properties,Usage,Production

Uses

assimilate cholesterol

Definition

ChEBI: (3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cho esterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity.

brand name

Baycol (Bayer);Cholstat.

in vivo

Cerivastatin is well absorbed, reaching maximal plasma levels in 1-3 hours following oral dosing. In the circulation, Cerivastatin is highly bound to plasma proteins (99.5%), with an elimination half-life of 2-4 hours. Cerivastatin is metabolized predominantly in the liver to three polar metabolites. Two of these metabolites are active, but to a lesser extent compared to parent drug, and the third metabolite is inactive. Plasma concentrations of all metabolites are substantially lower than those of the parent drug. Elimination of metabolites is via the urine (20-25%) and feces (66-73%), while essentially no parent compound is excreted[2].

CERIVASTATIN SODIUM Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

CERIVASTATIN SODIUM Suppliers

Leancare Ltd.
Tel
--
Fax
--
Email
enquiry@leancare.co.uk
Country
United Kingdom
ProdList
6446
Advantage
42
CARBONE SCIENTIFIC CO.,LTD
Tel
--
Fax
--
Email
sales@carbonesci.com
Country
United Kingdom
ProdList
6666
Advantage
30
Apin Chemicals Limited (UK)
Tel
--
Fax
--
Email
info@apinchemicals.com
Country
United Kingdom
ProdList
6184
Advantage
60
UK GREEN SCIENTIFIC CO.,LIMITED
Tel
--
Fax
--
Email
sales@gs-chem.com
Country
United Kingdom
ProdList
6098
Advantage
47
Apin Chemicals Ltd.
Tel
--
Fax
--
Email
info@apinchemicals.com
Country
United Kingdom
ProdList
6807
Advantage
42
Sequoia Research Products Ltd.
Tel
--
Fax
--
Email
sales@seqchem.com
Country
United Kingdom
ProdList
3113
Advantage
69

145599-86-6, CERIVASTATIN SODIUMRelated Search:


  • RIVASTATIN
  • sodium 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate
  • LIPOBAY
  • BAYCOL
  • CERIVASTATIN NA
  • CERIVASTATIN, SODIUM SALT
  • 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate
  • (3R,5S,6E)-7-[4-(p-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-6-heptenoic acid
  • 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, (3R,5S,6E)-
  • 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-, [S-[R*,S*-(E)]]-
  • (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-6-heptenoic acid
  • Cerivastatin
  • 6-[2-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)-3-pyridinyl]ethenyl]-4-hydroxy-2-oxanone
  • CERIVASTATIN SODIUM USP/EP/BP
  • Cerivastatin See C277000
  • 145599-86-6
  • C26H34FNO5
  • Active Pharmaceutical Ingredients